A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children
With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase
Research Question:
Does the drug Apixaban prevent blood clots in children with leukemia or lymphoma?
Basic Study Information
Purpose:
The purpose of this study is to compare the effect of a blood thinning drug called
Apixaban
versus no administration of a blood thinning drug, in preventing blood clots in children
with
leukemia or lymphoma. Patients must be receiving chemotherapy, including asparaginase,
and
have a central line (a catheter inserted for administration of medications and blood
sampling)
Location: University Of Rochester General Clinical Research Center
Lead Researcher (Principal Investigator)
Lead Researcher: Angela Girvin
Study Contact Information
Study Coordinator: Angela Girvin, Site 0064
Phone: (585) 275-5839
Email: Clinical.Trials@bms.com
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search